453 related articles for article (PubMed ID: 1796754)
1. Osteonectin is an alpha-granule component involved with thrombospondin in platelet aggregation.
Clezardin P; Malaval L; Morel MC; Guichard J; Lecompte T; Trzeciak MC; Dechavanne M; Breton-Gorius J; Delmas PD; Kaplan C
J Bone Miner Res; 1991 Oct; 6(10):1059-70. PubMed ID: 1796754
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.
Clezardin P; Serre CM; Trzeciak MC; Drouin J; Delmas PD
Cancer Res; 1991 May; 51(10):2621-7. PubMed ID: 1708697
[TBL] [Abstract][Full Text] [Related]
3. Functional involvement of thrombospondin in platelet aggregation induced by low versus high concentrations of thrombin.
Kao KJ; Shaut DM; Klein PA
Thromb Haemost; 1986 Feb; 55(1):136-42. PubMed ID: 3705001
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.
Boukerche H; McGregor JL
Eur J Biochem; 1988 Jan; 171(1-2):383-92. PubMed ID: 3338471
[TBL] [Abstract][Full Text] [Related]
5. Localization of platelet osteonectin at the internal face of the alpha-granule membranes in platelets and megakaryocytes.
Breton-Gorius J; Clezardin P; Guichard J; Debili N; Malaval L; Vainchenker W; Cramer EM; Delmas PD
Blood; 1992 Feb; 79(4):936-41. PubMed ID: 1737102
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.
Dubernard V; Legrand C
J Lab Clin Med; 1991 Nov; 118(5):446-57. PubMed ID: 1940585
[TBL] [Abstract][Full Text] [Related]
7. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
8. Aggregation to thrombin and collagen of platelets from a Glanzmann thrombasthenic patient lacking glycoproteins IIb and IIIa.
McGregor L; Hanss M; Sayegh A; Calvette JJ; Trzeciak MC; Ville D; Catimel B; Viala JJ; Dechavanne M; McGregor JL
Thromb Haemost; 1989 Nov; 62(3):962-7. PubMed ID: 2595666
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa
Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086
[TBL] [Abstract][Full Text] [Related]
10. [Identification of human platelet specific functional antibody and its fragments].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
[TBL] [Abstract][Full Text] [Related]
12. Interaction of a Monoclonal Antibody to Glycoprotein IV (CD36) with Human Platelets and its Effect on Platelet Function.
Legrand C; Pidard D; Beiso P; Tenza D; Edelman L
Platelets; 1991; 2(2):99-105. PubMed ID: 21047285
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of Fc-receptor dependent platelet aggregation by monoclonal antibodies against the glycoprotein IIb-IIIa complex].
Vinogradov DV; Vlasik TN; Agafonova OG; Vasil'ev SA; Lagutina NIa; Makarov VA; Berndt M; Mazurov AV
Biokhimiia; 1991 May; 56(5):787-97. PubMed ID: 1747408
[TBL] [Abstract][Full Text] [Related]
14. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
15. Studies on platelets of patients with inherited platelet disorders suggest that collagen-induced fibrinogen binding to membrane receptors requires secreted ADP but not released alpha-granule proteins.
Legrand C; Nurden AT
Thromb Haemost; 1985 Oct; 54(3):603-6. PubMed ID: 3003952
[TBL] [Abstract][Full Text] [Related]
16. Role of thrombospondin in platelet aggregation.
Leung LL
J Clin Invest; 1984 Nov; 74(5):1764-72. PubMed ID: 6501568
[TBL] [Abstract][Full Text] [Related]
17. Thrombin receptor occupancy modulates aggregation efficiency and platelet surface expression of vWF and thrombospondin at low thrombin concentrations.
Kasirer-Friede A; Legrand C; Frojmovic MM
Thromb Haemost; 1999 Jun; 81(6):967-75. PubMed ID: 10404777
[TBL] [Abstract][Full Text] [Related]
18. Human platelet osteonectin: release, surface expression, and partial characterization.
Kelm RJ; Mann KG
Blood; 1990 Mar; 75(5):1105-13. PubMed ID: 2306517
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
[TBL] [Abstract][Full Text] [Related]
20. Dauricine inhibits redistribution of platelet membrane glycoprotein IV and release of intracellular alpha-granule thrombospondin induced by thrombin.
Guo T; Zhang YZ; Liu DX; Zou P; Shen D
Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):533-6. PubMed ID: 10678148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
